Talia Puzantian, PharmD, BCPP

Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.

Clinical Update

Considerations in Prescribing Lithium in Older Adults

October 1, 2024

Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP

Shireen Wissa, PharmD Candidate 2025. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.

Risks in Older Adults

Antidepressants and Hyponatremia

April 1, 2024

Heather Robles, PharmD and Talia Puzantian, PharmD, BCPP

Heather Robles, PharmD candidate, and Talia Puzantian, PharmD, BCPP. Ms. Robles and Dr. Puzantian have no financial relationships with companies related to this material.

A brief review of hyponatremia including medications that cause it, symptoms to look out for, and how to prevent and treat this common side effect.

Fact Sheet

Lurasidone (Latuda) Fact Sheet [G] for General Psychiatry

January 1, 2024

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Lurasidone offers advantages such as no need for titration, once-daily dosing, relatively low–moderate metabolic risk, and low QT prolongation risk.

News of Note

Brexpiprazole

October 31, 2023

Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP

Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease.

Fact Sheet

Valproic Acid (Depakene, Depakote, others) Fact Sheet [G] for Children and Adolescents

September 23, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Along with lithium, valproate is a first-line antimanic agent for acute manic episodes in kids.

Fact Sheet

Olanzapine (Lybalvi, Symbyax, Zyprexa) Fact Sheet [G] for Children and Adolescents

September 23, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Its high risk for weight gain and metabolic complications make it a second-line choice for kids and adolescents. Consider co-administering metformin to prevent weight gain.

Fact Sheet

General Tips on Child and Adolescent Psychopharmacology

September 23, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Here are some hard-won tips and pearls that you might find useful in your practice.